ADMA BIOLOGICS, INC. Repayments of Other Debt
ADMA BIOLOGICS, INC. (ADMA) reported Repayments of Other Debt of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherDebt · last filed 2020-03-13
- ADMA BIOLOGICS, INC. repayments of other debt for the quarter ending 2019-12-31 was $0.00.
- ADMA BIOLOGICS, INC. repayments of other debt for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- ADMA BIOLOGICS, INC. repayments of other debt for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- ADMA BIOLOGICS, INC. repayments of other debt for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- ADMA BIOLOGICS, INC. repayments of other debt for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- ADMA BIOLOGICS, INC. repayments of other debt for fiscal 2018 was $19.70K, a 18.95% increase from fiscal 2017.
- ADMA BIOLOGICS, INC. repayments of other debt for fiscal 2017 was $16.56K.
| Period end | Repayments of Other Debt 3 month | Repayments of Other Debt 6 month | Repayments of Other Debt 9 month | Repayments of Other Debt 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $0.00 derived: sum of 2 quarters · filed 2020-03-13 | $0.00 derived: sum of 3 quarters · filed 2020-03-13 | $0.00 10-K · filed 2020-03-13 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 4 quarters · filed 2020-03-13 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | $0.00 derived: sum of 3 quarters · filed 2020-03-13 | $10.84K derived: sum of 4 quarters · filed 2020-03-13 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 | $0.00 derived: sum of 2 quarters · filed 2020-03-13 | $10.84K derived: sum of 3 quarters · filed 2020-03-13 | $15.32K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $10.84K derived: sum of 2 quarters · filed 2020-03-13 | $15.32K derived: sum of 3 quarters · filed 2020-03-13 | $19.70K 10-K · filed 2020-03-13 |
| 2018-09-30 | $10.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $15.32K derived: sum of 2 quarters · filed 2019-11-06 | $19.70K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $4.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $8.85K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $4.38K 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $16.56K 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |